Chiara Grazia De Ciucis

Chiara Grazia De Ciucis

Auto-generated profile, based on publicly available information

Chiara Grazia De Ciucis


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2024 in Research in Veterinary Science
Verified
Journal Article
Open access
BCBarbara Chirullo
Barbara Chirullo
FFFloriana Fruscione
Floriana Fruscione
GZGenny Del Zotto
Genny Del Zotto
FAFilippo Dell Anno
Filippo Dell Anno
MTMichela Tarantino
Michela Tarantino
ERElisabetta Razzuoli
Elisabetta Razzuoli
Bacteria-mediated treatments gained increasing attention as alternative therapies against tumors. An attenuated mutant strain of Salmonella enterica serovar Typhimurium (STMzznuABC) has recently been considered as a potential new anti-cancer strategy. However, it is unclear whether this activity is tumor-induced or speciesspecific, and no data are available regarding STMzznuABC on canine mammary tumors (CMTs). This study aimed to investigate the ability of STMzznuABC in modulating the response of CMTs, focusing on cancerassociated fibroblasts. Four CMT cell lines (CF33, TM51, TM52 TM53) were treated with STMzznuABC. Then, antiproliferative activity (MTT assay), bacterial invasion, and CMT cell lines gene expression analysis (RT-qPCR) of genes involved in immune response and cancer aggressiveness were evaluated. STMzznuABC penetrated in TM51, TM52, TM53, and CF33 cell lines, causing a significant reduction of cell viability. Moreover, the expression of several genes was significantly modulated in all CMT cell lines: STMzznuABC infection determined a significant up-regulation of CXCL8, IL18, IL10, TLR4 and RAD51, while CD14, IL6, CXCR4, P53, PTEN, STAT5, TLR5 and TGFB1 were downregulated in TM53. In CF33, CXCL8 and P53 were upregulated, while MYD88, MD2, IL18, TLR4,5, TGFB1 were downregulated. In TM52, CXCL8, CD44 and MD2 were upregulated and PTEN was downregulated, while in TM51 CXCL8, CD44 and ErbB2 were downregulated. We demonstrated the antiproliferative and immuno-modulatory activity of STMzznuABC in CMTs, paving the way for potential new anti-cancer treatments.

14 August 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
FAFilippo Dell Anno
Filippo Dell Anno
Chiara TrebinoChiara Trebino
Chiara Trebino
FFFloriana Fruscione
Floriana Fruscione
CCChiara Grazia De Ciucis
Chiara Grazia De Ciucis
LPLivia De Paolis
Livia De Paolis
ERElisabetta Razzuoli
Elisabetta Razzuoli
Equine sarcoid is the most common cutaneous neoplasm of equids and represents a distinctive model of virus-associated tumor persistence. Although bovine papillomaviruses, particularly BPV-1 and BPV-2, are recognized as the main etiological agents, viral infection alone does not fully explain the clinical heterogeneity, frequent recurrence, and limited spontaneous regression of these lesions. This review summarizes current evidence on the molecular and cellular mechanisms underlying equine sarcoid pathogenesis, with emphasis on the interaction between BPV infection, host signaling pathways, tumor microenvironment dynamics, and multi-omic evidence of host regulatory networks. BPV oncoproteins, especially E5, promote fibroblast transformation through PDGFβR activation, downstream PI3K/AKT, MAPK and p38 signaling, altered cell survival, and immune evasion mediated by impaired antigen presentation. However, sarcoid persistence appears to depend on broader host-driven processes, including extracellular matrix remodeling, activated fibroblastic and myofibroblastic phenotypes, chronic inflammatory signaling, and ineffective immune clearance. Recent transcriptomic and epigenomic studies further indicate that long non-coding RNAs, DNA methylation changes, circulating microRNAs, and recently identified virus–host chimeric transcripts may contribute to stabilization of the neoplastic phenotype and may represent future biomarkers. Overall, this review proposes a virus-initiated, host-sustained conceptual framework for equine sarcoid pathogenesis, in which viral oncogene activity and host tissue reprogramming cooperate to promote lesion persistence, recurrence, and therapeutic resistance.